Cargando…

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism

Toll-like receptor 9 (TLR9) triggering is a promising novel strategy to combat cancer as it induces innate and adaptive immunity responses. B-cell lymphoma is unique in this context as tumor cells express TLR9 and may harbor latent Epstein-Barr virus (EBV), a gamma-herpesvirus with remarkable oncoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noack, J, Jordi, M, Zauner, L, Alessi, D, Burch, A, Tinguely, M, Hersberger, M, Bernasconi, M, Nadal, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388232/ https://www.ncbi.nlm.nih.gov/pubmed/22717578 http://dx.doi.org/10.1038/cddis.2012.60

Ejemplares similares

IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt’s lymphoma cells
por: Jordi, Marc, et al.
Publicado: (2017)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines
por: Israely, Tomer, et al.
Publicado: (2014)

Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists
por: Lacerte, Patricia, et al.
Publicado: (2016)

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
por: González-Reyes, Salomé, et al.
Publicado: (2010)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis
por: Roshan, Mohsin H. K., et al.
Publicado: (2016)

Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy
por: Bremer, Paul T., et al.
Publicado: (2014)

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
por: Cascini, Caterina, et al.
Publicado: (2023)

TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
por: Schleimann, Mariane H., et al.
Publicado: (2019)

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
por: Younes, Ahmed I., et al.
Publicado: (2020)

Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production
por: Lee, Jinhee, et al.
Publicado: (2015)

TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis
por: Lauriello, Maria, et al.
Publicado: (2012)

Below the surface: The inner lives of TLR4 and TLR9
por: Marongiu, Laura, et al.
Publicado: (2019)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome
por: Saha, Subhrajit, et al.
Publicado: (2012)

The Immunomodulatory Effect of Bone-Marrow Mesenchymal Stem Cells on Expression of TLR3 and TLR9 in Mice Dendritic Cells
por: Sadeghi, L., et al.
Publicado: (2017)

Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation
por: Derkow, Katja, et al.
Publicado: (2015)

Synergistic Induction of Interferon α through TLR-3 and TLR-9 Agonists Identifies CD21 as Interferon α Receptor for the B Cell Response
por: Kim, Dhohyung, et al.
Publicado: (2013)

Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility
por: Pandey, Nilesh O., et al.
Publicado: (2019)

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma
por: Zhou, Zhimei, et al.
Publicado: (2021)

Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate “altered” cells?
por: Sommariva, Michele, et al.
Publicado: (2012)

Possible role of TLR4 and TLR9 SNPs in protection against congenital toxoplasmosis
por: Wujcicka, W., et al.
Publicado: (2015)

Genetic variation of TLR-4, TLR-9 and TIRAP genes in Iranian malaria patients
por: Zakeri, Sedigheh, et al.
Publicado: (2011)

An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
por: Zhang, Huagang, et al.
Publicado: (2012)

Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703
por: Schmidt, Manuel, et al.
Publicado: (2015)

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015)

Prediction of novel mouse TLR9 agonists using a random forest approach
por: Khanna, Varun, et al.
Publicado: (2019)

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists
por: Bai, Ling, et al.
Publicado: (2023)

Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus
por: Azab, Marwa M., et al.
Publicado: (2022)

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
por: Zhao, Xingli, et al.
Publicado: (2018)

TLR9 and Glioma: Friends or Foes?
por: Fehri, Emna, et al.
Publicado: (2022)

TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells
por: Suthers, Amy N., et al.
Publicado: (2017)

TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
por: Zambirinis, Constantinos P., et al.
Publicado: (2015)

B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice
por: Cosgrove, Haylee A., et al.
Publicado: (2023)

Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility
por: Chauhan, Alex, et al.
Publicado: (2019)

Glycyrrhizin Interacts with TLR4 and TLR9 to Resolve P. aeruginosa Keratitis
por: Somayajulu, Mallika, et al.
Publicado: (2022)

IL-1R8 Downregulation and Concomitant TLR7 and TLR9 Upregulation Are Related to the Pathogenesis of Canine Diffuse Large B-Cell Lymphoma
por: Riva, Federica, et al.
Publicado: (2022)

Impaired Innate Immunity in Tlr4 (−/−) Mice but Preserved CD8(+) T Cell Responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-Deficient Mice
por: Oliveira, Ana-Carolina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dr915vb63r6s5ans5g5f3hq2ou